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Introduction
Nasal mucus is the first line defense barrier against various
allergens. Proteins are functional molecules in mucus and
have different roles especially in immune response. Apoli-
poproteins are plasma proteins that are mainly involved in
lipid metabolism, but also have anti-inflammatory proper-
ties. The role of this study was to identify apolipoproteins
in nasal mucus of allergic rhinitis patients and healthy
controls.
Methods
Fifty-eight individuals (31 male, 27 female) were included
in this study. Mean age was 34 years (range: 20-58 years)
comprising 29 (50%) allergic rhinitis patients and 29 (50%)
healthy controls. Allergy status was verified by skin prick
tests and specific IgE. Mucus was taken using a special
suction device with a mucus trap and samples were sent
for (LC MS/MS) mass spectrometry. Spectral counts (SC)
were then obtained and experimental spectra were com-
pared with public databases.
Results
Apolipoprotein A-IV, Apolipoprotein B-100 were newly
identified in nasal mucus and were exclusively present in
allergic rhinitis patients not reaching significance. Apoli-
poprotein A-1 (mean SC=19 vs. 6) and A-2 (mean SC=9
vs. 1) were significantly more abundant in allergic rhinitis
patients than healthy controls (3.2 fold and 9.7 fold respec-
tively). Other significantly more abundant proteins were
Alpha-2-macroglobulin, Alpha1 antitrypsin and Comple-
ment C3.
Conclusion
Since apolipoproteins were found to have antimicrobial
activities and anti-inflammatory properties their significant
abundance of Apolipoproteins A-1 and A-2 as well as the
presence of Apolipoprotein A-IV and Apolipoprotein
B-100 reflect the inflammatory state of allergic rhinitis
mucosa and mucus. Moreover they are a marker of
increased plasma exsudation into nasal mucus and
increased epithelial permeability. The corresponding
changes in plasma concentration needs to be determined.
This knowledge, however, could serve as an additional
marker of severity of inflammation through simple blood
samples in allergic rhinitis patients and a plausible local
substitution of apolipoproteins could be the target of new
anti-inflammatory drugs.
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